The up-regulation of downstream target genes of this pathway, such as metallothionein-1G [32] and ATP binding cassette subfamily C member 5 [33] can inhibit cell ferroptosis and enhance the resistance of HCC cells to sorafenib [34]. Here, MT1G is linked to hepatocellular carcinoma.